What Is Astigmatism?
Astigmatism is a common eye problem. The problem is caused by imperfections in the curvature of your eyes causing blurred distance or near vision. Normally your corneas and eye lens are smooth and uniformly curved in all directions. Astigmatism is a refractive error caused by the irregular shape of your cornea.
Astigmatism is a common eye problem that can usually occur with myopia (nearsightedness) or hyperopia (farsightedness). We can diagnose the problem with a simple eye exam.
Astigmatism is a refractive error and is not an eye disease. Your eye has a problem focusing light.
Astigmatism can be because of a congenital defect or can occur when you are older. Some people have a combination of myopia and hyperopia.
Symptoms
Symptoms of astigmatism are:-
• Blurry vision or distorted vision.
• Eye strain or discomfort.
• Squinting your eyes to see clearly.
• Headache
• Difficulty seeing at night.
Book an ophthalmologist in Mumbai if you have any of these symptoms or your vision prevents you from enjoying or interfere with everyday tasks. Children may not realize they have eye problems you should get your child’s vision tested periodically.
Causes
Astigmatism is caused by asymmetrically shaped corneas. Our eye has two curved surfaces (cornea and lens) that refract light onto your retina. When the cornea and lens are perfectly shaped you get a focused image on your retinas.
Refractive error is caused when either your lens or cornea has mismatched curves. The imperfect refractive images cause blurred images. The blurred vision may be horizontal direction, vertical or diagonal direction.
Astigmatism can be a congenital defect or may develop after an injury or surgery. The condition is not caused or made worse by reading in poor light, sitting too close to the television or squinting.
There are three types of Astigmatism are:-
• Myopic astigmatism is when your cornea has curved too much or your eye is longer than normal. The condition makes distant objects look blurry.
• Hyperopia occurs when your cornea has curved too little or your eye is shorter than normal. The condition makes the near object look blurry.
• Mixed astigmatism occurs when your corneas are irregularly shaped. One eye may have myopia and the other hyperopia.
Diagnosis
The best ophthalmologist in Mumbai will diagnose astigmatism during an eye examination. During the examination, they will check the health of your eyes.
They may use the following tests:-
Visual acuity assessment test – you will have to read letters and numbers from a chart.
The Refractive test uses a machine called optical refractor where the ophthalmologist near me tries to find the lens while you read the letter and number chart.
Keratometry helps the ophthalmologist determine the curvature of your cornea.
Treatment
The best ophthalmologist in Mumbai treats mild-to-moderate astigmatism by prescribes eyeglasses or contact lenses. The glasses or contact lenses help to compensate for the uneven curvature of your cornea or lens.
Orthokeratology (ortho-K) a procedure where you wear rigid contact lenses at night to even out the curvature of your eyes. You were the lenses less frequently to maintain the newly corrected shape.
The ophthalmologist near me may suggest a refractive surgery. Small knives or laser is used to reshape the curves of your cornea. Since it is laser surgery, there are some risks associated with the procedures. Discuss the pros and cons with your doctor.
It is important to treat astigmatism as soon as possible. Once diagnosed, you need to visit your ophthalmologist to make sure prescription has not changed.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...
Continue Reading
SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...
Continue Reading
Turning the Tide on Pharmacy Costs The world of pharmacy benefits is getting a long-overdue shake-up, courtesy of a new rule mandating transparency from the pharmacy benefit managers (PBMs). This ain't your everyday administrative tweak—it's a seismic shift for the 136 million Americans tied into employer-sponsored health plans. Thanks to the U.S. Department of Labor...
Continue Reading
Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...
Continue Reading
Trading on the Go Takes a Leap Forward Pretty slick development from TIOmarkets, if I do say so myself. They've rolled out a major expansion of their mobile trading app, now packing some hefty features like Depth of Market and more granular order controls right from those little devices in our pockets. Quite the leap if you're one of those folks who can't keep your eyes...
Continue Reading
Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....
Continue Reading
Equitable Bank Dials Up Its Prime Rate Equitable Bank's taken a step that every borrower and investor out there can't ignore: they've hiked their prime lending rate by 25 basis points, pushing it up to 4.70% from 4.45%. Now, any old-timer in the trading arena knows that when banks shift their rates, it's not just numbers on paper—it ripples across the landscape, from...
Continue Reading
A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...
Continue Reading
Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...
Continue Reading
Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...
Continue Reading
Top 5 Most Recently Viewed Articles
Bullfrog AI's Financial Moves to Propel Future Growth BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) is setting the stage for substantial growth with its latest financial initiatives. WallachBeth Capital announced that the company has entered into a definitive agreement for the sale of approximately 1,565,000 shares of common stock through a registered direct offering....
Continue Reading
New Leadership in the UK Market Aclarion, Inc. is excited to announce the appointment of Dan Isherwood as the new UK Commercial Director. This strategic hire marks a significant milestone for the company, enhancing its capacity to penetrate the UK healthcare market effectively. With a robust background in HealthTech, Isherwood is poised to help drive the utilization of...
Continue Reading
Navigating Travel Insurance Amidst Potential Government Shutdowns As uncertainties loom regarding potential government shutdowns, travelers find themselves questioning how these events might disrupt their plans. A looming government shutdown often leads to numerous challenges, including staffing shortages at key agencies such as the FAA and TSA. These essential services,...
Continue Reading
Immuthera's Scientific Advisory Board: Innovation at the Forefront Immuthera, a leading name in the field of cell therapies, is thrilled to introduce its newly assembled Scientific Advisory Board. This esteemed group includes renowned experts like Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman. Their collective expertise will drive innovative solutions in...
Continue Reading
Astroport and Orbit Fab Team Up for Lunar Exploration Astroport Space Technologies, Inc., a leader in advanced space exploration solutions, and Orbit Fab, Inc., renowned for in-space refueling and resource utilization, have announced an exciting partnership aimed at accelerating lunar infrastructure development. This collaboration marks a pivotal moment in the quest for...
Continue Reading